Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

I believe it would be wise for Gerald to resolve the Chill issue before releasing any meaningful news. Letts keep in mind that releasing MANF Orphan drug data does not have any relation to it being an FDA based news driven event. Specifically, the goal is to identify and indicate what areas MANF could be effective that would accelerate the possibility that the FDA could expedite approval down the road.

Since AMBS and BD have collaborated months in advance of the lab certification announcement; its possible that the LymPro program is much further along then most might be aware of ...hence, its Geralds call as to time communicating the progress with meeting the next milestone.

BlackH - I think you are trying to provide a bullet proof logical argument as to why companies should or should not release news on an immediate basis or when know......but as publicly traded companies are heavily aligned to Wall Street (it will never surprise me to see any CEO time the market to get the best positive upside with the PPS (its common sense).